KN-62 is a selective calmodulin-dependent protein kinase II (CaMKII) inhibitor and also a potent non-competitive P2X7 receptor antagonist[1][2]. CaMKII is a serine/threonine kinase that plays a critical role in calcium signaling by phosphorylating various substrates involved in neurotransmission, muscle contraction, and other cellular processes[3]. P2X7 is an ATP-gated ion channel belonging to the P2X receptor family, which is activated by high concentrations of extracellular ATP and mediates inflammatory responses and cell death[4]. KN-62 is usually used in the research of neural signal transduction, inflammatory response and tumor metastasis mechanisms[5].
In vitro, treatment of tamoxifen-resistant MCF-7 cells with KN-62 (3μM; 24h) inhibits ATP-induced calcium influx, cell proliferation and migration, and reduces small extracellular vesicle secretion and CD63 expression[6].
In vivo, KN-62 (1μg/site; i.c.v.) reversed the ZnCl₂-induced reduction in immobility time in the tail suspension test in Swiss mice[7].
References:
[1] Schweitzer ES, Sanderson MJ, Wasterlain CG. Inhibition of regulated catecholamine secretion from PC12 cells by the Ca2+/calmodulin kinase II inhibitor KN-62. J Cell Sci. 1995;108 ( Pt 7):2619-2628.
[2] Gargett CE, Wiley JS. The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes. Br J Pharmacol. 1997;120(8):1483-1490.
[3] Reyes Gaido OE, Nkashama LJ, Schole KL, et al. CaMKII as a Therapeutic Target in Cardiovascular Disease. Annu Rev Pharmacol Toxicol. 2023;63:249-272.
[4] Sluyter R. The P2X7 Receptor. Adv Exp Med Biol. 2017;1051:17-53.
[5] Pellicena P, Schulman H. CaMKII inhibitors: from research tools to therapeutic agents. Front Pharmacol. 2014;5:21.
[6] Park M, Kim J, Phuong NTT, et al. Involvement of the P2X7 receptor in the migration and metastasis of tamoxifen-resistant breast cancer: effects on small extracellular vesicles production. Sci Rep. 2019;9(1):11587.
[7] Manosso LM, Moretti M, Ribeiro CM, Gonçalves FM, Leal RB, Rodrigues ALS. Antidepressant-like effect of zinc is dependent on signaling pathways implicated in BDNF modulation. Prog Neuropsychopharmacol Biol Psychiatry. 2015;59:59-67.
















